Cargando…
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216087/ https://www.ncbi.nlm.nih.gov/pubmed/34155200 http://dx.doi.org/10.1038/s41467-021-24300-8 |
| _version_ | 1783710352507142144 |
|---|---|
| author | Xie, Xuping Muruato, Antonio E. Zhang, Xianwen Lokugamage, Kumari G. Fontes-Garfias, Camila R. Zou, Jing Liu, Jianying Ren, Ping Balakrishnan, Mini Cihlar, Tomas Tseng, Chien-Te K. Makino, Shinji Menachery, Vineet D. Bilello, John P. Shi, Pei-Yong |
| author_facet | Xie, Xuping Muruato, Antonio E. Zhang, Xianwen Lokugamage, Kumari G. Fontes-Garfias, Camila R. Zou, Jing Liu, Jianying Ren, Ping Balakrishnan, Mini Cihlar, Tomas Tseng, Chien-Te K. Makino, Shinji Menachery, Vineet D. Bilello, John P. Shi, Pei-Yong |
| author_sort | Xie, Xuping |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8216087 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82160872021-06-21 Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 Xie, Xuping Muruato, Antonio E. Zhang, Xianwen Lokugamage, Kumari G. Fontes-Garfias, Camila R. Zou, Jing Liu, Jianying Ren, Ping Balakrishnan, Mini Cihlar, Tomas Tseng, Chien-Te K. Makino, Shinji Menachery, Vineet D. Bilello, John P. Shi, Pei-Yong Nat Commun Author Correction Nature Publishing Group UK 2021-06-21 /pmc/articles/PMC8216087/ /pubmed/34155200 http://dx.doi.org/10.1038/s41467-021-24300-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Xie, Xuping Muruato, Antonio E. Zhang, Xianwen Lokugamage, Kumari G. Fontes-Garfias, Camila R. Zou, Jing Liu, Jianying Ren, Ping Balakrishnan, Mini Cihlar, Tomas Tseng, Chien-Te K. Makino, Shinji Menachery, Vineet D. Bilello, John P. Shi, Pei-Yong Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 |
| title | Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 |
| title_full | Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 |
| title_fullStr | Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 |
| title_full_unstemmed | Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 |
| title_short | Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 |
| title_sort | author correction: a nanoluciferase sars-cov-2 for rapid neutralization testing and screening of anti-infective drugs for covid-19 |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216087/ https://www.ncbi.nlm.nih.gov/pubmed/34155200 http://dx.doi.org/10.1038/s41467-021-24300-8 |
| work_keys_str_mv | AT xiexuping authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT muruatoantonioe authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT zhangxianwen authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT lokugamagekumarig authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT fontesgarfiascamilar authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT zoujing authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT liujianying authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT renping authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT balakrishnanmini authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT cihlartomas authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT tsengchientek authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT makinoshinji authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT menacheryvineetd authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT bilellojohnp authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 AT shipeiyong authorcorrectionananoluciferasesarscov2forrapidneutralizationtestingandscreeningofantiinfectivedrugsforcovid19 |